BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18623608)

  • 1. Intention-to-treat analysis in cluster randomized trials with noncompliance.
    Jo B; Asparouhov T; Muthén BO
    Stat Med; 2008 Nov; 27(27):5565-77. PubMed ID: 18623608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster randomized trials with treatment noncompliance.
    Jo B; Asparouhov T; Muthén BO; Ialongo NS; Brown CH
    Psychol Methods; 2008 Mar; 13(1):1-18. PubMed ID: 18331150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.
    Moerbeek M; Schie SV
    Stat Med; 2019 Nov; 38(26):5071-5084. PubMed ID: 31578760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models.
    Wu Y; Zhao L; Hou Y; Li K; Zhou X
    Stat Med; 2015 Mar; 34(6):950-65. PubMed ID: 25534903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination for testing equality in a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):1-17. PubMed ID: 21191850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustment for compliance behavior in trials of epidural analgesia in labor using instrumental variable meta-analysis.
    Bannister-Tyrrell M; Miladinovic B; Roberts CL; Ford JB
    J Clin Epidemiol; 2015 May; 68(5):525-33. PubMed ID: 25592169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Method to Estimate the Efficacy vs. Effectiveness in Meta-Analysis of Clinical Trials with Different Adherence Scenarios: A Monte Carlo Simulation Study in Nutrition.
    López-Espinoza MÁ; Lozano-Lozano JA; Prieto-Merino D
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.